<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pyc Therapeutics Limited — News on 6ix</title>
    <link>https://6ix.com/company/pyc-therapeutics-ltd</link>
    <description>Latest news and press releases for Pyc Therapeutics Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 07 May 2026 03:23:15 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/pyc-therapeutics-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836693178dffbe2df15f04e.webp</url>
      <title>Pyc Therapeutics Limited</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd</link>
    </image>
    <item>
      <title>PKD - Initiation of Multiple Dose Clinical Trial</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-initiation-of-multiple-dose-clinical-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-initiation-of-multiple-dose-clinical-trial</guid>
      <pubDate>Thu, 07 May 2026 03:23:15 GMT</pubDate>
      <description>PKD - Initiation of Multiple Dose Clinical Trial</description>
    </item>
    <item>
      <title>Presentation of Ophthalmology Clinical Trial Data at ARVO</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/presentation-of-ophthalmology-clinical-trial-data-at-arvo</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/presentation-of-ophthalmology-clinical-trial-data-at-arvo</guid>
      <pubDate>Mon, 04 May 2026 03:35:12 GMT</pubDate>
      <description>Presentation of Ophthalmology Clinical Trial Data at ARVO</description>
    </item>
    <item>
      <title>ADOA Program - SRC Approve Progression to Multi-Dose Study</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-src-approve-progression-to-multi-dose-study</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-src-approve-progression-to-multi-dose-study</guid>
      <pubDate>Wed, 15 Apr 2026 05:14:11 GMT</pubDate>
      <description>ADOA Program - SRC Approve Progression to Multi-Dose Study</description>
    </item>
    <item>
      <title>Completion of Retail Entitlement Offer</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/completion-of-retail-entitlement-offer-10</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/completion-of-retail-entitlement-offer-10</guid>
      <pubDate>Wed, 04 Mar 2026 03:50:10 GMT</pubDate>
      <description>Completion of Retail Entitlement Offer</description>
    </item>
    <item>
      <title>PKD Clinical Trial - Approval to Escalate Dosing</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-clinical-trial-approval-to-escalate-dosing</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-clinical-trial-approval-to-escalate-dosing</guid>
      <pubDate>Fri, 27 Feb 2026 02:25:14 GMT</pubDate>
      <description>PKD Clinical Trial - Approval to Escalate Dosing</description>
    </item>
    <item>
      <title>Half Yearly Report and Accounts</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/half-yearly-report-and-accounts-129</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/half-yearly-report-and-accounts-129</guid>
      <pubDate>Mon, 23 Feb 2026 13:08:03 GMT</pubDate>
      <description>Half Yearly Report and Accounts</description>
    </item>
    <item>
      <title>Retail Offer Booklet</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/retail-offer-booklet-11</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/retail-offer-booklet-11</guid>
      <pubDate>Mon, 09 Feb 2026 03:42:18 GMT</pubDate>
      <description>Retail Offer Booklet</description>
    </item>
    <item>
      <title>Completion of Placement and Institutional Entitlement Offer</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/completion-of-placement-and-institutional-entitlement-offer-8</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/completion-of-placement-and-institutional-entitlement-offer-8</guid>
      <pubDate>Wed, 04 Feb 2026 04:01:06 GMT</pubDate>
      <description>Completion of Placement and Institutional Entitlement Offer</description>
    </item>
    <item>
      <title>PYC Raising up to $653m to Deliver Human Efficacy Data</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pyc-raising-up-to-dollar653m-to-deliver-human-efficacy-data</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pyc-raising-up-to-dollar653m-to-deliver-human-efficacy-data</guid>
      <pubDate>Mon, 02 Feb 2026 04:02:06 GMT</pubDate>
      <description>PYC Raising up to $653m to Deliver Human Efficacy Data</description>
    </item>
    <item>
      <title>PYC Capital Raising Presentation</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pyc-capital-raising-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pyc-capital-raising-presentation</guid>
      <pubDate>Mon, 02 Feb 2026 04:01:05 GMT</pubDate>
      <description>PYC Capital Raising Presentation</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/trading-halt-214</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/trading-halt-214</guid>
      <pubDate>Mon, 02 Feb 2026 03:37:06 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-15</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-15</guid>
      <pubDate>Fri, 23 Jan 2026 03:11:04 GMT</pubDate>
      <description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>PKD Clinical Trial - Safety Outcomes in Part A</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-clinical-trial-safety-outcomes-in-part-a</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pkd-clinical-trial-safety-outcomes-in-part-a</guid>
      <pubDate>Fri, 19 Dec 2025 03:48:09 GMT</pubDate>
      <description>PKD Clinical Trial - Safety Outcomes in Part A</description>
    </item>
    <item>
      <title>Sustained Vision Improvement in RP11 Patients</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/sustained-vision-improvement-in-rp11-patients</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/sustained-vision-improvement-in-rp11-patients</guid>
      <pubDate>Fri, 14 Nov 2025 02:40:12 GMT</pubDate>
      <description>Sustained Vision Improvement in RP11 Patients</description>
    </item>
    <item>
      <title>ADOA Program Initiation of Global Repeat Dose Study</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-initiation-of-global-repeat-dose-study</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-initiation-of-global-repeat-dose-study</guid>
      <pubDate>Tue, 21 Oct 2025 02:37:18 GMT</pubDate>
      <description>ADOA Program Initiation of Global Repeat Dose Study</description>
    </item>
    <item>
      <title>PMS Program Data Supports Progression to Human Trials</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/pms-program-data-supports-progression-to-human-trials</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/pms-program-data-supports-progression-to-human-trials</guid>
      <pubDate>Mon, 13 Oct 2025 02:42:10 GMT</pubDate>
      <description>PMS Program Data Supports Progression to Human Trials</description>
    </item>
    <item>
      <title>ADOA Program Progressing to Multiple Dose Study</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-progressing-to-multiple-dose-study</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/adoa-program-progressing-to-multiple-dose-study</guid>
      <pubDate>Thu, 09 Oct 2025 02:54:19 GMT</pubDate>
      <description>ADOA Program Progressing to Multiple Dose Study</description>
    </item>
    <item>
      <title>Board and Management Changes</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/board-and-management-changes-12</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/board-and-management-changes-12</guid>
      <pubDate>Mon, 22 Sep 2025 02:53:18 GMT</pubDate>
      <description>Board and Management Changes</description>
    </item>
    <item>
      <title>Correction to Trading Halt Request</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/correction-to-trading-halt-request</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/correction-to-trading-halt-request</guid>
      <pubDate>Fri, 19 Sep 2025 04:21:04 GMT</pubDate>
      <description>Correction to Trading Halt Request</description>
    </item>
    <item>
      <title>Change of Managing Director</title>
      <link>https://6ix.com/company/pyc-therapeutics-ltd/news/change-of-managing-director</link>
      <guid isPermaLink="true">https://6ix.com/company/pyc-therapeutics-ltd/news/change-of-managing-director</guid>
      <pubDate>Wed, 17 Sep 2025 02:49:00 GMT</pubDate>
      <description>Change of Managing Director</description>
    </item>
  </channel>
</rss>